Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02517554 · ClinicalTrials.gov registry record
A Study Of TeleGenetics Versus Usual Care To Increase Access To Cancer Genetic Services
A clinical trial, sponsored by Abramson Cancer Center at Penn Medicine.
- Completed
- Registry status
- 120
- Enrollment target
NCT02517554 is a clinical trial that has completed, run by Abramson Cancer Center at Penn Medicine. The registered enrollment target is 120 participants.
The verdict
NCT02517554 has completed, sponsored by Abramson Cancer Center at Penn Medicine.
- COMPLETED
- Registry status
- 120 participants
- Enrollment target
Study Summary
The goal of this research is to evaluate the relative advantage of remote counseling over usual care in community health practices without access to genetic services. We will evaluate ability of remote telemedicine, referred to going forward as TeleGenetic services (phone or videoconferencing), to increase uptake of genetic testing and identification of genetic carriers compared to usual care. Secondly, we will evaluate the advantages of videoconferencing over telephone for delivery of remote genetic services and the short-term and longitudinal outcomes of TeleGenetic services in socio-demographically diverse patients in community practices.
Interventions
- BEHAVIORAL Penn genetic counselors provides counseling and test results disclosure by videoconferene to patient at community site
- BEHAVIORAL Penn genetic counselor provides counseling and test results disclosure by telephone to patient at community site
- BEHAVIORAL Patient receives written information on how to find genetic services in their area
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2015-08 |
| Est. Completion | 2019-11 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02517554
The ClinicalTrials.gov registry entry for NCT02517554 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Abramson Cancer Center at Penn Medicine, which has 402 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Penn genetic counselors provides counseling and test results disclosure by videoconferene to patient at community site is the first listed.
NCT02517554 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02517554 about?
NCT02517554 is a clinical study titled "A Study Of TeleGenetics Versus Usual Care To Increase Access To Cancer Genetic Services". The goal of this research is to evaluate the relative advantage of remote counseling over usual care in community health practices without access to genetic services. We will evaluate ability of remote telemedicine, referred to going forward as TeleGenetic services (phone or videoconferencing), to i...
What is the current status of trial NCT02517554?
This trial is currently completed. The enrollment target is 120 participants. The study started on 2015-08. Estimated completion is 2019-11.
What interventions are being tested in trial NCT02517554?
The interventions under investigation include: Penn genetic counselors provides counseling and test results disclosure by videoconferene to patient at community site (BEHAVIORAL), Penn genetic counselor provides counseling and test results disclosure by telephone to patient at community site (BEHAVIORAL), Patient receives written information on how to find genetic services in their area (BEHAVIORAL).
Who is sponsoring clinical trial NCT02517554?
This trial is sponsored by Abramson Cancer Center at Penn Medicine, which has 402 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.